This invention relates to dicycloalkylcarbamoyl ureas of formula (I), which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
本发明涉及公式(I)的二环烷基
氨基甲酰
脲,它们是
葡萄糖激酶的激活剂,因此可能对增加
葡萄糖激酶活性有益的疾病的管理、治疗、控制或辅助治疗有用。